Bristol Myers Squibb (BMY) closed the latest trading day at $56.30, indicating a -0.95% change from the previous session's end. The stock fell short of the S&P 500, which registered a loss of 0.09% for the day. Meanwhile, the Dow gained 0.04%, and the Nasdaq, a tech-heavy index, lost 0.1%.Heading into today, shares of the biopharmaceutical company had lost 1.8% over the past month, outpacing the Medical sector's loss of 2.1% and lagging the S&P 500's loss of 0.29% in that time.Investors will be eagerly watc ...